Myelodysplastic syndrome, an acquired clonal disorder of the bone marrow, is a common cause of unexplained anemia in North American adults older than 65 years.
1 Most cases are idiopathic, although some are related to prior chemotherapy or radiotherapy. Men are affected more commonly than women. The median age at diagnosis is 76 years, and the incidence rises to 36.4 cases/ 100 000 population per year in those over 80 years.
2 As the population ages, rates will increase. An interactive decision tool for the investigation and management of active treatment for myelodysplastic syndrome is available at www.MDSclearpath.org. The development of this tool was funded by Celgene Canada.
